Report
Letter from the Board of Directors
Key figures
Company profile
Sales and markets
Financial and sustainability discussion
Novozymes' stock
About the report
Outlook
Letter from the CEO
Long-term targets
Expectations for 2011
Management
Board of Directors
Executive Management
Corporate governance
Risk management
Risk factors
Accounts
Income statement
Statement of comprehensive income
Balance sheet
Statement of shareholders' equity
Statement of cash flows and financial resources
Environmental and social data
Notes
Group companies
Statements
Financial statements for Novozymes A/S
Supplementary reporting
GRI indicators
Site data
Global Compact - Communication on Progress
LCA studies
To novozymes.com
|
Download report
|
Privacy
|
Legal
|
Sitemap
Search result
Close
0 pages added
Novozymes’ Executive Management group on 2010
SEE ALL VIDEOS
›
Novozymes starts commercial supply of new hyaluronic acid
09.05.2012
Novozymes has started to supply Novozymes Hyasis®, a novel pharmaceutical-grade hyaluronic acid, from its newly opened facility. The product targets medical device and pharmaceutical markets with an estimated volume of DKK 1 billion.
Novozymes provides input for UN Global Compact to make sustainable change in the textile industry
03.05.2012
In collaboration with the Danish Fashion Institute, Novozymes provides advice to UN Global Compact with the aim of creating sustainable change in the textile industry.
Accounts
Ambitions
Biofuel
BPI
Climate
CO
2
Detergents
Environment
Global Compact
GRI
Growth
Investments
LCA
Markets
Microorganisms
Resources
Results
Sales
Social responsibility
Stock
Sustainability
Targets
